In vivo selection reveals autophagy promotes adaptation of metastatic ovarian cancer cells to abdominal microenvironment.

Cancer Science
Chih-Lin KuoChing-Wei Luo

Abstract

Peritoneal dissemination is the most frequent metastatic route of ovarian cancer. However, due to the high heterogeneity in ovarian cancer, most conventional studies lack parental tumor controls relevant to metastases and, thus, it is difficult to trace the molecular changes of cancer cells along with the selection by the abdominal microenvironment. Here, we established an in vivo mouse peritoneal dissemination scheme that allowed us to select more aggressive sublines from parental ovarian cancer cells, including A2780 and SKOV-3. Microarray and gene profiling analyses indicated that autophagy-related genes were enriched in selected malignant sublines. Detection of LC3-II, p62 and autophagic puncta demonstrated that these malignant variants were more sensitive to autophagic induction when exposed to diverse stress conditions, such as high cell density, starvation and drug treatment. As compared with parental A2780, the selected variant acquired the ability to grow better under high-density stress; however, this effect was reversed by addition of autophagic inhibitors or knockdown of ATG5. When analyzing the clinical profiles of autophagy-related genes identified to be enriched in malignant A2780 variant, 73% of them had prognos...Continue Reading

References

Feb 24, 2001·Histopathology·K M Feeley, M Wells
Dec 14, 2004·The New England Journal of Medicine·Stephen A Cannistra
Jun 2, 2005·Nature Reviews. Molecular Cell Biology·Eric H Baehrecke
Aug 17, 2005·Cancer Genetics and Cytogenetics·Vivian WangChristina A Bandera
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Nov 18, 2006·Cell·Gaorav P Gupta, Joan Massagué
Feb 15, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A A Ayantunde, S L Parsons
Aug 16, 2008·Human Pathology·Angela A SteinhardtRobert A Anders
Jul 24, 2010·The American Journal of Pathology·Ernst Lengyel
Apr 27, 2012·The Journal of Biological Chemistry·Andrea E Lo RéMartin E Fernandez-Zapico
Feb 22, 2013·Nature Reviews. Cancer·Emma KippsStan B Kaye
Mar 4, 2014·Oncotarget·Eran SchmuklerRonit Pinkas-Kramarski
May 6, 2014·The Journal of Biological Chemistry·Juan Wang, Gen Sheng Wu
Jan 6, 2015·Chinese Journal of Cancer·Bianca CheaibAlexandra Leary
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
May 29, 2016·Gynecologic Oncology·Lidia HernandezChristina M Annunziata
Nov 3, 2016·Breast Cancer Research and Treatment·András LánczkyBalázs Győrffy
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
xenograft
biopsy
xenografts

Software Mentioned

GSEA
MetaMorph

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.